Prevalence, diagnosis, and disease course of pertussis in adults with acute cough: A prospective, observational study in primary care

British Journal of General Practice

Volumn 65, Issue 639, 2015, Pages e662-e667

  Teepe, Jolien ^a   Broekhuizen, Berna D L ^a   Kretzschmar, Mirjam ^a   Verheij, Theo J M ^a   Ieven, Margareta ^b   Loens, Katherine ^b   Goossens, Herman ^b   Huygen, Kris ^c   De Melker, Hester ^d   Butler, Chris C ^e,f   Little, Paul ^g   Stuart, Beth ^g   Coenen, Samuel ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f CARDIFF UNIVERSITY   (United Kingdom)

^g UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Bordetella pertussis; Diagnosis; Prevalence; Primary care; Prognosis; Whooping cough

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; PERTUSSIS TOXIN; BACTERIUM ANTIBODY; IMMUNOGLOBULIN G;

ADULT; ADULT DISEASE; ANTIBODY TITER; ARTICLE; BELGIUM; BORDETELLA PERTUSSIS; COUGHING; DISEASE COURSE; DISEASE DURATION; DYSPNEA; FEMALE; FEVER; FRANCE; GERMANY; HEADACHE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; MYALGIA; NETHERLANDS; OBSERVATIONAL STUDY; PERTUSSIS; POLAND; PREVALENCE; PRIMARY MEDICAL CARE; PROSPECTIVE STUDY; SLEEP DISORDER; SLOVAKIA; SLOVENIA; SPAIN; SPUTUM; SWEDEN; THORAX PAIN; UNITED KINGDOM; WHEEZING; WORK DISABILITY; BLOOD; CLINICAL TRIAL; COUGH; EUROPE; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; POLYMERASE CHAIN REACTION; PRIMARY HEALTH CARE; WHOOPING COUGH;

ADULT; ANTIBODIES, BACTERIAL; BORDETELLA PERTUSSIS; COUGH; EUROPE; HUMANS; IMMUNOGLOBULIN G; PERTUSSIS TOXIN; POLYMERASE CHAIN REACTION; PREVALENCE; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; WHOOPING COUGH;

EID: 84943269401     PISSN: 09601643     EISSN: 14785242     Source Type: Journal    
DOI: 10.3399/bjgp15X686917     Document Type: Article

References (19)

1. von König CH, Halperin S, Riffelmann M, Guiso N. Pertussis of adults and infants. Lancet Infect Dis 2002; 2(12): 744-750.
2. Lee GM, Lebaron C, Murphy TV, et al. Pertussis in adolescents and adults: should we vaccinate Pediatrics 2005; 115(6): 1675-1684.
3. Zepp F, Heininger U, Mertsola J, et al. Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect Dis 2011; 11(7): 557-570.
4. Crowcroft NS, Pebody RG. Recent developments in pertussis. Lancet 2006; 367(9526): 1926-1936.
5. Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 2005; 24(5 Suppl): S58-S61.
6. World Health Organization. Pertussis vaccines: WHO position paper. Wkly Epidemiol Rec 2010; 85(40): 385-400.
7. Lieberman D, Shvartzman P, Lieberman D, et al. Etiology of respiratory tract infection in adults in a general practice setting. Eur J Clin Microbiol Infect Dis 1998; 17(10): 685-689.
8. Gilberg S, Njamkepo E, Du Chətelet IP, et al. Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a French area with very high whole-cell vaccine coverage. J Infect Dis 2002; 186(3): 415-418.
9. Strebel P, Nordin J, Edwards K, et al. Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996. J Infect Dis 2001; 183(9): 1353-1359.
10. Miller E, Fleming DM, Ashworth LA, et al. Serological evidence of pertussis in patients presenting with cough in general practice in Birmingham. Commun Dis Public Health 2000; 3(2): 132-134.
11. Philipson K, Goodyear-Smith F, Grant CC, et al. When is acute persistent cough in school-Age children and adults whooping cough? A prospective case series study. Br J Gen Pract 2013; DOI: 10.3399/bjgp13X670705.
12. Butler CC, Hood K, Verheij T, et al. Variation in antibiotic prescribing and its impact on recovery in patients with acute cough in primary care: prospective study in 13 countries. BMJ 2009; DOI: 10.1136/bmj.b2242.
13. Schellekens JFP. Kinkhoestserologie. Ned Tijdschr Med Microbiol 2013; 21: 107-112.
14. European Centre for Disease Prevention and Control. Recommended immunisations for pertussis. http://vaccine-schedule.ecdc.europa.eu/Pages/Scheduler.aspx (accessed 14 Aug 2015).
15. European Centre for Disease Prevention and Control. Annual epidemiological report on communicable diseases in Europe. Rev, edn. Stockholm: ECDC, 2009. http://ecdc.europa.eu/en/publications/Publications/0910-SUR-Annual-Epidemiological-Report-on-Communicable-Diseases-in-Europe.pdf (accessed 10 Oct 2014).
16. de Melker HE, Schellekens JF, Neppelenbroek SE, et al. Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data. Emerg Infect Dis 2000; 6(4): 348-357.
17. De Greeff SC, Dekkers AL, Teunis P, et al. Seasonal patterns in time series of pertussis. Epidemiol Infect 2009; 137(10): 1388-1395.
18. Donker GA. Continuous Morbidity Registration Dutch Sentinel General Practice Network 2012. www.nivel.nl/sites/default/files/bestanden/Rapport-continuousmorbidity-registration-dutch-sentinel-2012.pdf (accessed 14 Aug 2015).
19. Dalby T, Petersen JW, Harboe ZB, Krogfelt KA. Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine. J Med Microbiol 2010; 59(Pt 9): 1029-1036.